Orhan Kemal Yücel
Scientific work
Selected peer-reviewed publications.
-
2017Cancer«Cytogenetics and comorbidity predict outcomes in older myelodysplastic syndrome patients after allogeneic stem cell transplantation using reduced intensity conditioning»· first author
-
2021Leukemia & Lymphoma«Prognostic impact of the psoas muscle index, a parameter of sarcopenia, in patients with diffuse large B-cell lymphoma treated with rituximab-based chemoimmunotherapy»· co-author
-
2023Oncology (Switzerland)«Lower Body Mass Index and Prognostic Nutritional Index Are Associated with Poor Posttransplant Outcomes in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation»· first author
-
2024Turkish Journal of Hematology«Survival Outcomes of Patients with Primary Plasma Cell Leukemia in the Era of Proteasome Inhibitors and Immunomodulatory Agents»· co-author
-
2022Turkish Journal of Hematology«Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies»· co-author
-
2020Indian Journal of Hematology and Blood Transfusion«Conventional Cytogenetics and Interphase Fluorescence In Situ Hybridization Results in Multiple Myeloma: A Turkey Laboratory Analysis of 381 Cases»· co-author
Where they practise
Direct contract with BergemHealth at every listed clinic.
Tell me about your case — I’ll read it personally.
Fill in the short form on the consultation page — diagnosis, preferred timing, attached records. We assemble a tumour board for your case and reply within 4 hours.
Open the consultation form- Reply within 4 hours during business hours
- Confidentiality guaranteed
- Coordinator-translator inside the doctor’s office
- Tumour board of 2–3 professors within 72 hours
Similar BergemHealth professors
Adjacent specialties and second opinions. Direct contracts, verified cases.